O8.08 * CIC MUTATION IS A POOR PROGNOSIS FACTOR IN 1P19Q CODELETED GLIOMAS, ASSOCIATED TO AN UP-REGULATION OF PROLIFERATION PATHWAYS
Vincent Gleize(Centre National de la Recherche Scientifique), Marc Sanson(Centre National de la Recherche Scientifique), François Ducray(Centre National pour la Recherche Scientifique et Technique (CNRST)), Agustí Alentorn(Allen Institute for Brain Science), Léa Connen de Kérillis(Centre National de la Recherche Scientifique), Karima Mokhtari(Inserm), Marianne Labussière(Centre National de la Recherche Scientifique), Stephanie Mangesius(Innsbruck Medical University), Chiara Villa(Centre National de la Recherche Scientifique)
Cited by 1
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797